Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cross Country Healthcare (CCRN) Capital Expenditures: 2009-2024

Historic Capital Expenditures for Cross Country Healthcare (CCRN) over the last 16 years, with FY2024 value amounting to $8.7 million.

  • Cross Country Healthcare's Capital Expenditures rose 9492.88% to $2.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.9 million, marking a year-over-year decrease of 551.65%. This contributed to the annual value of $8.7 million for FY2024, which is 3764.13% down from last year.
  • Latest data reveals that Cross Country Healthcare reported Capital Expenditures of $8.7 million as of FY2024, which was down 3764.13% from $14.0 million recorded in FY2023.
  • Over the past 5 years, Cross Country Healthcare's Capital Expenditures peaked at $14.0 million during FY2023, and registered a low of $4.6 million during FY2020.
  • Moreover, its 5-year median value for Capital Expenditures was $8.7 million (2024), whereas its average is $8.7 million.
  • Its Capital Expenditures has fluctuated over the past 5 years, first skyrocketed by 5904.85% in 2023, then tumbled by 3764.13% in 2024.
  • Annual analysis of 5 years shows Cross Country Healthcare's Capital Expenditures stood at $4.6 million in 2020, then soared by 55.36% to $7.2 million in 2021, then grew by 22.54% to $8.8 million in 2022, then soared by 59.05% to $14.0 million in 2023, then tumbled by 37.64% to $8.7 million in 2024.
  • Its last three reported values are $8.7 million in FY2024, $14.0 million for FY2023, and $8.8 million during FY2022.